Literature DB >> 16705285

Quality of life outcomes related to anemia management of patients with chronic renal failure.

Reta Hamilton1, Sheila Hawley.   

Abstract

PURPOSE: The purpose of this study was to evaluate the impact of a clinical nurse specialist-managed outpatient anemia management program on quality of life for patients with anemia related to chronic kidney disease. DESCRIPTION OF THE STUDY: A retrospective study was conducted using information from the Medical Outcomes Short Form 36 Item Health Survey, which is completed by patients with anemia at their initial, 3-month, 6-month, and 12-month visits, and annually thereafter. Thirty-four patients completed the 3-month survey, 19 completed the 6-month survey, and 10 completed the 12-month survey. OUTCOMES: There was a statistically significant increase in quality of life indicators at the 3 and 6 months' interval. The increase in physical and decrease in mental indicators were not substantiated through the 12-month interval.
CONCLUSION: Quality of life was significantly improved for patients in a clinical nurse specialist-managed outpatient anemia management program.

Entities:  

Mesh:

Year:  2006        PMID: 16705285     DOI: 10.1097/00002800-200605000-00011

Source DB:  PubMed          Journal:  Clin Nurse Spec        ISSN: 0887-6274            Impact factor:   1.067


  2 in total

Review 1.  Biomarkers and health-related quality of life in end-stage renal disease: a systematic review.

Authors:  Brennan M R Spiegel; Gil Melmed; Sean Robbins; Eric Esrailian
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-01       Impact factor: 8.237

2.  Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients.

Authors:  Bin Wang; Qing Yin; Yu-Chen Han; Min Wu; Zuo-Lin Li; Yan Tu; Le-Ting Zhou; Qing Wei; Hong Liu; Ri-Ning Tang; Jing-Yuan Cao; Lin-Li Lv; Bi-Cheng Liu
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.